AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Heartflow, Inc. Common Stock

$49.88 +$20.91 (+72.18%)
NASDAQ · 11 Sep 2026 20:00 UTC
Previous Close
$45.49
Day Range
$45.63$50.18
Year Range
$20.13$51.78
Market Cap
4.3B
AVG Volume
1.67M
Trailing/Forward PE
-35.13/-
PEG ratio
0.92
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
NASDAQUS
Revenue (USD) · TTM
0100M200M300M24 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HTFL Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
26 Q2212.07M
26 Q1191.42M
25 Q4176.03M
25 Q3161.88M
25 Q2148.54M
25 Q1136.17M
24 Q4125.81M
Net Income (USD) · TTM
-150M-100M-50M024 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HTFL Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
26 Q2-118.37M
26 Q1-111.83M
25 Q4-116.79M
25 Q3-125.37M
25 Q2-93.66M
25 Q1-107.84M
24 Q4-96.43M
Operating Income (USD) · TTM
-80M-60M-40M-20M024 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HTFL Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
26 Q2-72.77M
26 Q1-68.59M
25 Q4-64.07M
25 Q3-62.37M
25 Q2-62.2M
25 Q1-62.67M
24 Q4-61.22M
EBITDA (USD) · TTM
-150M-100M-50M024 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HTFL EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
26 Q2-108.23M
26 Q1-92.88M
25 Q4-93.12M
25 Q3-96.3M
25 Q2-62.78M
25 Q1-77.74M
24 Q4-65.47M
Cash Flows (USD) · TTM
-80M-60M-40M-20M024 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HTFL Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
26 Q2-59.18M
26 Q1-76.77M
25 Q4-59.05M
25 Q3-60.92M
25 Q2-68.02M
25 Q1-63.74M
24 Q4-73.36M
EPS (USD) · TTM
-2-1.5-1-0.5024 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HTFL EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
26 Q2-1.42
26 Q1-1.35
25 Q4-1.54
25 Q3-1.77
25 Q2-1.44
25 Q1-1.7
24 Q4-1.52
Expenses (USD) · TTM
0100M200M300MR&DSG&ACapex24 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HTFL Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
26 Q2249.55M
26 Q1223.82M
25 Q4204.29M
25 Q3188.22M
25 Q2177.35M
25 Q1169.34M
24 Q4160.03M
Shares Outstanding · TTM
-30M-20M-10M024 Q425 Q125 Q225 Q325 Q426 Q126 Q2
HTFL Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
26 Q2-23.69M
26 Q1-18.03M
25 Q4-13.96M
25 Q3-11.22M
25 Q2-9.6M
25 Q1-9.98M
24 Q4-10.21M
Employee Count
02505007501K2025
HTFL Employee Count by quarter
PeriodEmployee Count
2025843
Free Cash Flow Yield
-4%-3%-2%-1%med -2.66%Aug 25Oct 25Jan 26Mar 26May 26Jul 26Sep 26
HTFL Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-1.37%
Sep 26-1.4%
Aug 26-1.43%
Aug 26-1.38%
Aug 26-1.63%
Aug 26-3.11%
Jul 26-3.55%
Jul 26-3.72%
Jul 26-3.6%
Jul 26-3.36%
Jul 26-3.21%
Jun 26-2.51%
Jun 26-2.66%
Jun 26-2.7%
Jun 26-3.19%
May 26-2.89%
May 26-3.04%
May 26-3.17%
May 26-2.35%
May 26-2.42%
Apr 26-2.27%
Apr 26-2.21%
Apr 26-2.57%
Apr 26-2.79%
Mar 26-2.8%
Mar 26-2.66%
Mar 26-3.69%
Mar 26-3.29%
Feb 26-3.26%
Feb 26-3.01%
Feb 26-3.66%
Feb 26-2.72%
Jan 26-2.53%
Jan 26-2.35%
Jan 26-2.03%
Jan 26-2.28%
Jan 26-2.61%
Dec 25-2.53%
Dec 25-2.48%
Dec 25-2.85%
Dec 25-2.75%
Nov 25-2.34%
Nov 25-2.45%
Nov 25-2.7%
Nov 25-2.59%
Oct 25-2.27%
Oct 25-2.23%
Oct 25-2.5%
Oct 25-2.52%
Oct 25-2.24%
Sep 25-2.55%
Sep 25-2.57%
Sep 25-2.99%
Sep 25-3.21%
Aug 25-3.17%
Aug 25-3.42%
Aug 25-3.2%
Aug 25-3.47%
Price to Sales
10152025med 14.59Aug 25Oct 25Jan 26Mar 26May 26Jul 26Sep 26
HTFL Price to Sales by quarter
PeriodPrice to Sales
Sep 2620.32
Sep 2619.93
Aug 2619.47
Aug 2620.27
Aug 2617.14
Aug 2612.89
Jul 2611.29
Jul 2610.79
Jul 2611.13
Jul 2611.95
Jul 2612.51
Jun 2615.95
Jun 2615.05
Jun 2614.87
Jun 2612.57
May 2613.86
May 2613.19
May 2612.67
May 2614.3
May 2613.89
Apr 2614.75
Apr 2615.18
Apr 2613.06
Apr 2612.03
Mar 2611.96
Mar 2612.61
Mar 2610.2
Mar 2611.44
Feb 2611.53
Feb 2612.5
Feb 2610.29
Feb 2613.81
Jan 2614.88
Jan 2616.02
Jan 2618.51
Jan 2616.5
Jan 2614.43
Dec 2514.86
Dec 2515.19
Dec 2513.19
Dec 2513.71
Nov 2516.06
Nov 2515.36
Nov 2513.93
Nov 2517.67
Oct 2520.17
Oct 2520.55
Oct 2518.33
Oct 2518.17
Oct 2520.43
Sep 2517.94
Sep 2517.84
Sep 2515.65
Sep 2514.57
Aug 2514.77
Aug 2513.68
Aug 2514.62
Aug 2513.48
Price to Book
57.51012.51517.5med 8.75Nov 25Jan 26Feb 26Apr 26Jun 26Jul 26Sep 26
HTFL Price to Book by quarter
PeriodPrice to Book
Sep 2615.41
Sep 2615.11
Aug 2614.76
Aug 2615.37
Aug 2613
Aug 268.64
Jul 267.56
Jul 267.23
Jul 267.46
Jul 268.01
Jul 268.38
Jun 2610.69
Jun 2610.08
Jun 269.96
Jun 268.42
May 269.29
May 268.84
May 268.49
May 268.37
May 268.13
Apr 268.63
Apr 268.89
Apr 267.64
Apr 267.04
Mar 267
Mar 267.38
Mar 266.49
Mar 267.28
Feb 267.33
Feb 267.95
Feb 266.54
Feb 268.78
Jan 269.46
Jan 2610.18
Jan 2611.77
Jan 2610.49
Jan 269.17
Dec 259.45
Dec 259.66
Dec 258.39
Dec 258.72
Nov 2510.21
Nov 259.77
Nov 258.86
Heartflow, Inc. Common Stock
HTFL
Stockpicker

Video analysis: HTFL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: HTFL

Heartflow (NASDAQ:HTFL) versus American Well (NYSE:AMWL) Financial Analysis

defenseworld.net · 11 Sep 2026

Heartflow (NASDAQ:HTFL) versus American Well (NYSE:AMWL) Financial Analysis

American Well (NYSE: AMWL - Get Free Report) and Heartflow (NASDAQ: HTFL - Get Free Report) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, profitability, analyst recommendations, earnings, valuation and risk. Valuation and Earnings This table compares American Well and

HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High

fool.com · 6 Sep 2026

HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High

The sale of 33,416 shares generated a total value of approximately $1.7 million based on a weighted average execution price of $49.85. The traded shares represent 13% of the equity stake held by the officer before the transaction.

Baron SMID Cap ETF Q2 2026 Portfolio Activity

seekingalpha.com · 4 Sep 2026

Baron SMID Cap ETF Q2 2026 Portfolio Activity

During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufacturer of stormwater and onsite wastewater management products. We view Axon Enterprise as a market leading "atoms plus electrons" software provider with huge competitive moats. We sold the HeartFlow position in the quarter as we grew incrementally more concerned with the presence of competitors on the market.

Bank of New York Mellon Corp Makes New $19.10 Million Investment in Heartflow, Inc. $HTFL

defenseworld.net · 1 Sep 2026

Bank of New York Mellon Corp Makes New $19.10 Million Investment in Heartflow, Inc. $HTFL

Bank of New York Mellon Corp bought a new stake in shares of Heartflow, Inc. (NASDAQ: HTFL) during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund bought 650,849 shares of the company's stock, valued at approximately $19,096,000. Bank of New York Mellon Corp owned

BlackRock Inc. Makes New $152.50 Million Investment in Heartflow, Inc. $HTFL

defenseworld.net · 29 Aug 2026

BlackRock Inc. Makes New $152.50 Million Investment in Heartflow, Inc. $HTFL

BlackRock Inc. acquired a new stake in Heartflow, Inc. (NASDAQ: HTFL) in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 5,197,747 shares of the company's stock, valued at approximately $152,502,000. BlackRock Inc. owned 6.03% of Heartflow at the end of

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

globenewswire.com · 28 Aug 2026

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting Appropriate Use Criteria for cath lab referrals FUSION trial presented at ESC and published in Journal of the American College of Cardiology demonstrates adding non-invasive lesion-specific physiology resolves critical diagnostic uncertainty, supporting Appropriate Use Criteria for cath lab referrals

Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference

globenewswire.com · 27 Aug 2026

Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference

SAN FRANCISCO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for diagnosing and managing coronary artery disease (CAD), today announced that members of management will participate in a fireside chat at the upcoming Wells Fargo 21st Annual Healthcare Conference. The fireside chat, which will include a slideshow presentation followed by a question-and-answer session, will take place in Boston on Wednesday, September 9, 2026, at 3:45 p.m. ET / 12:45 p.m. PT.

HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?

fool.com · 20 Aug 2026

HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?

The executive sold 9,219 shares at $41.23 per share on August 17, 2026, generating ~$380,100. The transaction reduced the insider's direct equity position by 10%, while total beneficial ownership decreased by 4%.

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.